This is the authors' abstract. We don't add key points for this paper.
substitution through a spirocyclic dearomatized intermediate. This platform expands access to arylethylamines from cycloalkanols.
No takes yet. Share an insight, caveat, or question.
Bashir et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: